chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had taken J&J vaccine in April of 2021.  Was preparing to do the booster.  Ended up with a COVIDE breakthrough infection.  Admitted to hospital November 16 through the 19th .  Diagnosed with COVID pneumonia an a pulmonary blood clot.  Subsequent with PCP follow up now have high blood pressure 200/101 and a heart murmur.  The heart murmur was not heard during the hospitalization.  I believe this is the result of the COVID infection perhaps compounded by vaccination.
After receiving second dose on 1/16 I experienced a fever of 102 F, headache, and tachycardia. I took acetaminophen after 12 hours of symptoms and every 6 hours after that for 24 hours and the symptoms have not returned.
High pitched buzzing in head, about 5 mins afterwards. I had to wait the 15 mins in the pharmacy after the vaccine and it started within that time period. Then I had insomnia, and didn't sleep for over a week. Not sure when that passed, I was exhausted and wired, so wired. I literally could not sleep. I didn't take any type of medicine for it, but I still have the ringing in my head, not really in my ears.
Injection site hot to the touch; Injection site Hard; Injection Site became red; Injection site swelling; Injection site Itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Injection site hot to the touch), INJECTION SITE INDURATION (Injection site Hard), INJECTION SITE ERYTHEMA (Injection Site became red), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PRURITUS (Injection site Itching) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M204) for COVID-19 vaccination.     The patient's past medical history included Breast cancer and Hypertension. Concurrent medical conditions included Drug allergy (Vancomycin), Drug allergy (Piperacillin/tazobactam), Drug allergy (Linezolid) and Drug allergy (Trimethoprim/sulfamethoxazole). Concomitant products included DOXYCYCLINE for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE WARMTH (Injection site hot to the touch), INJECTION SITE INDURATION (Injection site Hard), INJECTION SITE ERYTHEMA (Injection Site became red), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PRURITUS (Injection site Itching). At the time of the report, INJECTION SITE WARMTH (Injection site hot to the touch), INJECTION SITE INDURATION (Injection site Hard), INJECTION SITE ERYTHEMA (Injection Site became red), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PRURITUS (Injection site Itching) had not resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-012977 (Patient Link).
Patient reported feeling nauseous nearly immediately after vaccination and retreated to the store bathroom. Upon arrival, I found him profusely diaphoretic and very pale. He reported some difficulty breathing and was wheezing when speaking. He did vomit briefly. An epinephrine 0.3 mg auto injector was administered to his right thigh pending the arrival of emergency services.
Missed the appointment for second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported
13 year old patient received Pfizer Pediatric 5-11 instead of Pfizer >12
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 27-JAN-2014, patient received improperly stored (Oka/Merck) VARIVAX dose 2, from lot # H018451 (dose and expiry date unknown) (incorrect product storage). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received form the same reporter. Additional information has been requested.
Patient developed redness/swelling at site of injection with progression of swelling/redness to elbow and shoulder-non-circumferential.  patient also had bone "achiness" for 3 days.  Redness and swelling improved in about 1 week.  No other symptoms.  Patient back to baseline.
No adverse effects were reported in the patient; a vaccine following a temperature excursion; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant therapy was unknown.   On 29-OCT-2019, the patient was vaccinated with one dose of hepatitis a vaccine, inactivated (VAQTA) (dose, strength, route, lot# and expiration date were unknown) for prophylaxis following a temperature excursion.   Temperature excursion was reported as below 36 Fahrenheit (F)/2 Celsius degrees (C) (35F) for 430 minutes. There was no previous temperature excursion. No digital data logger was involved.   No adverse effects were reported in the patient.
got shingles; Severe Pain all over/ suffering; not get out of bed; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th January 2022, the patient received Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced shingles, general body pain and bedridden. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the shingles, general body pain and bedridden were recovering/resolving.   The reporter considered the shingles, general body pain and bedridden to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix vaccine and experienced severe pain, shingles and could not get out of bed for 10 days. The reporter contacted patient's HCP (health care professional) and was able to get in within 48 hours to be seen.  The HCP prescribed Valacyclovir for patient to use 3 times a day, and it had helped with some of the pain. This was the first day patient had gotten out of her bed, but was still in a great deal of pain. The reporter stated that after her suffering for 10 days, being in bed, severe pain, and all the things that went with shingles. The patient's husband provided his opinion about the fact that the patient had to gone through all of these things because of the vaccine that GlaxoSmithKline made, that's the main problem. The reporter consented to follow-up.
Headache, Myalgia, Arthralgia, NauseaVomiting, malaise, chills Narrative:
Patient called complaining of a fever of 103-plus degrees F, headache, vomiting, legs swelling, increased coughing, and some shortness of breathe.
Prior to presenting to ED, patient had presented to his PCP with incased cough and dyspnea where he was started on steroid taper thinking it was likely a COPD exacerbation, Covid test later returned as positive. Patient presented to ED on 8/24/21 with covid and was treated appropriately. Patient was discharged on 8/29/21.
Patient presented to ED with sudden onset shortness of breath, with associated chest pain and palpitations. The patient was found to be tachycardic at 129 bpm. The patient was found to have atrial fibrillation with rapid ventricular response. The patient spontaneously converted to NSR prior to medications being given. The patient is admitted to the hospital.
very ill at the moment; throwing up to the point of not being able to keep water in; having joint aches; injection site is red; injection site is red and swollen; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very ill at the moment), VOMITING (throwing up to the point of not being able to keep water in), ARTHRALGIA (having joint aches), INJECTION SITE ERYTHEMA (injection site is red) and INJECTION SITE SWELLING (injection site is red and swollen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021 at 7:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced ILLNESS (very ill at the moment), VOMITING (throwing up to the point of not being able to keep water in), ARTHRALGIA (having joint aches), INJECTION SITE ERYTHEMA (injection site is red) and INJECTION SITE SWELLING (injection site is red and swollen). At the time of the report, ILLNESS (very ill at the moment), VOMITING (throwing up to the point of not being able to keep water in), ARTHRALGIA (having joint aches), INJECTION SITE ERYTHEMA (injection site is red) and INJECTION SITE SWELLING (injection site is red and swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
On 12/8/99, the pt experienced chickenpox with low grade fever, itching, and greater than ten crusting lesions and papules. He was seen by a physician.
headache, body aches, fever, brain fog, dizziness,  leg pains,
Information was received from a medical assistant who stated that approximately a total of 20 patients (demographics unknown) were administered either GARDASIL (case #1403USA013058) or ROTATEQ (dates of administration, dosage and route of administration not provided) that was improperly stored. No adverse effects reported. Additional information has been requested.
Mother called to report. Patient began to complain of tingling and "heavy" legs on 8/8/19.  Patient went to ER the evening of 8/10/19 with complete leg paralysis. Patient was admitted to Pediatric ICU. Mom states patient had a low but normal potassium so they gave her a potassium drip and she was discharged 8/12/19 with better function. Still not completely recovered. Mother states she is having trouble concentrating and keeping her balance. Patient is seeing Dr. and Neurologist.
Patient had varicella vaccine 8/1/00. Came into MD office today (6/7/05) with varicella disease (>30 pox sites).
This spontaneous report was received from a healthcare worker and refers to a 9 week old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 22-JUN-2015 and on 31-AUG-2015, the patient was vaccinated with two separate doses of improperly stored ROTATEQ (doses were not provided) lot # K015816, expiration date: 29-MAR-2016 and lot # K 0123534, expiration date: 22-MAY-2016, orally. No adverse effects were reported. Additional information has been requested.
Patient states that the morning after the shot site became red and painful. Upon visiting our pharmacy on 11-9-18, she showed me the area and it looked reddish, she says it was warm and painful. I advised her to place cool towels on the area, to take BENADRYL and to inform her physician doctor.
HIGH FEVER of 103.6 rectally, very fussy, unaware of all surroundings.
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th July 2019, the patient received the 1st dose of Shingrix. On 11th July 2019, 2 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The registered pharmacist reported that the patient received Shingrix and at the time of reporting was diagnosed with Shingles.
c/o "sick stomach", shaky, jittery, chills/hot + "feeling just different, not myself" No diff. breathing, swelling or rash.  Patient vomited while talking with her mother.  Mother will call PMP, Dr or take her to a clinic per mother.  5-8-09 T/c with pt's mother, who stated, "her condition got worse, she continued to vomite, her eyes rolled up into her head and she stopped breathing."  Mother stated that the emergency MD released her stating she was just having a "panic attack".  Pt is also allergic to Benadryl which was given to pt (mother had not mentioned the allergy to ER staff or H.D. staff when initiating VEARS form.)
Fever x 5 days. Vaccines administered 3 pm that night had febrile seizure while sleeping lasting approx 1 minute. Had been tired, low activity until Day 6.
1 day after receiving vaccine patient developed hives on the face only which resolved in 24 hours
Second dose of Moderna COVID19 Vaccine was given 5 days early on 9/1/21.  First dose was administered 8/9/21.  Scheduling error was made.  Team members were coached.  Patient was informed of event.
This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, less than a month after receiving BEXSERO, the patient experienced injection site pain. On and unknown date, the outcome of the injection site pain was unknown. The reporter considered the injection site pain to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. One month prior from the time of reporting the patient received 1st dose of BEXSERO. The patient returned to doctor of medicine's office for the 2nd dose of BEXSERO. During visit to the office, the patient stated that the pain from the 1st dose had recently ceased. This case has been linked with the case US2016153388, reported by the same reporter.
Information has been received from a female receptionist at the physician's office concerning herself who on an unknown date was vaccinated with a dose of GARDASIL. After getting the vaccine, she experienced fainted. Subsequently, the patient recovered from fainted. It was unspecified if the patient sought medical attention. No further information is available.
had body ache / body's ache from head to toe; HEADACHE; discomfort; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, couple of weeks after receiving Shingrix, the patient experienced general body pain, headache and general discomfort. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the general body pain, headache and general discomfort were unknown.   It was unknown if the reporter considered the general body pain, headache and general discomfort to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient experienced general body pain, headache and general discomfort. This case was linked with case US2020AMR035766, reported by the same reporter for the same patient.
Pt has been on Vioxx for 1 week. Received flu shot and started itching within 2 hours on back of neck. Pt also has raised areas on back of neck and nausea.
Rt. arm swollen, hot, itchy. Physician diagnosed staph infection and cellulitis on 10/9/09,
24 hours after shot had hallucinations, then 3 days later started having sore throat, lost voice, and scratchy chest feeling.  no fever, no cough, no sob.
Nausea, vomiting, and unbearable headaches.; Nausea, vomiting, and unbearable headaches.; Nausea, vomiting, and unbearable headaches.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Batch/Lot number: unknown) as dose 1, single and administration date 06May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), VOMITING (non-serious), HEADACHE (non-serious), outcome "unknown" and all described as "Nausea, vomiting, and unbearable headaches."  Additional information: The reporter wanted to check when will the symptoms subside. She was experiencing Nausea, vomiting, and unbearable headaches. She got the first dose last 15Apr and got the 2nd dose last 06May.  No follow-up attempts are possible. No further information is expected.
onset of fever 27APR99 temp was never taken;rash began on 29APR99 generalized;day of report 3MAY99;rash resolved;lymph swelling on both sided of neck started 1MAY99 cont to day;
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult male patient who received SHINGRIX for prophylaxis. On 18th March 2019, the patient received SHINGRIX. On 18th March 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm, pain, headache and chills. On an unknown date, the outcome of the pain in arm, pain, headache and chills were unknown. It was unknown if the reporter considered the pain in arm, pain, headache and chills to be related to SHINGRIX. Additional details were provided as follows: The patient experienced pain in arm, pain, headache and chills after receiving SHINGRIX vaccine. There was no consent to follow up.
"jumping around activity" going on and it's getting worse; Her legs have been twitching and has gone up her back; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS ("jumping around activity" going on and it's getting worse) and MUSCLE TWITCHING (Her legs have been twitching and has gone up her back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CARBIDOPA, LEVODOPA (CARBIDOPA LEVODOPA) and CLONAZEPAM for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS ("jumping around activity" going on and it's getting worse) and MUSCLE TWITCHING (Her legs have been twitching and has gone up her back). At the time of the report, NERVOUSNESS ("jumping around activity" going on and it's getting worse) and MUSCLE TWITCHING (Her legs have been twitching and has gone up her back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had their second shot due on 31 Mar 2021. No treatment information was provided.   Reporter did not allow further contact
Vaccine was administered in drive thru. I pulled out after and into one of the waiting spots. About 10 minutes after I was suddenly drenched in sweat and started to see black. My left side of body started to feel a burning sensation. I had been told to honk and put on flashers if anything went wrong. I did and waited more than 30 minutes. No one ever came to check me. After about 10 more minutes I started to feel better but was still pale and my face looked slightly puffy. I never saw anyone so I eventually drove home, drank a ton of water, ate some saltines and then slept a little. Had chills off and on that day and remained tired the next day. Felt fine by day 3
Information has been received from a certified registered nurse practitioner concerning a 22 year old white female with an allergy to amoxicillin, azithromycin (Zpack) and seasonal allergies and no known illness at time of vaccination who on /1968U), IM, left 09-JUL-2008 at 11:00 AM was vaccinated with first dose of GARDASIL vaccine (yeast) (Lot# 660389/1968U) (Dose not reported). Concomitant therapy included YASMIN. On 09-JUL-2008, the patient received her first dose of GARDASIL vaccine (yeast) and at 11:10 AM she became "light headed, hot, felt funny, stomach ache, cool, pale, clammy skin, faint pulse". The nurse could not get her blood pressure and the office had to call 911 to send her to hospital via squad. Approximately 1 hour later on the same day, the patient called the office back and said she was feeling fine and was released from hospital and that it was a Vaso Vagal reaction. The patient recovered from the Vaso Vagal reaction. Additional information is not expected.
0830:Pt c/o "dizzyness", 0835: BP 78/45,P:47, T:96.1, Spo2%99. Pt instructed to wait in observation area and drink water. 0843:BP: 93/58. No medical hx, no medications, pt stated "feeling much better". 0912:BP:110/70, P:64, T: 98.6, Spo2: 97% RA, Pt stated "feeling Great",Pt instructed to keep hydrated. 0917: Pt instructed to call PCP if symptoms return, pt released. -RN
4:30am Woke up with severe chills, fever 102+, headache.  Lasted about 3 hours.  Following day, no appetite, felt tired, Low grade fever 99.8.  Second night, - night sweats.    Took Ibuprofen and Tylenol greater that 12 hours after vaccine.
Chest heaviness, lightheaded. Evaluated by EMS-Transported to Emergency room/department or urgent care.
Five day level 10 migraine. I had fever and chills. I used prescribed medication and went to the hospital and was turned away.
Pt recvd vax JUL92 & 2 to 3 wks later pt exp coughing, congestion, low grade fever, lightheadedness & joint pains; no further details were provided;
Information has been received from a pharmacist concerning a patient (demographics unspecified) who on an unspecified date was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. Subsequently the patient had an allergic reaction. The pharmacist had no further details on the allergic reaction. The patient sought unspecified medical attention. Additional information has been received.
Administration error: MMR given on 11/3/2022 and Varicella given on 11/4/2022 at the same facility. Time and spacing between 2 lives vaccines invalidated the varicella given on 11/4/2022.
Nerve pain, fatigue, brain fog, low heart rate -tots, joint and muscle pain, congestion, and chills
Developed sx of herpes zoster on 10/29.  Received influenza vaccine on 10/26. Dx w/ herpes zoster on 11/1.
Fever, body aches/chills, headache, fatigue, increased blood sugar levels, and numbness in toes. Item 20 clarification...fever, body aches/chills, headache, fatigue resolved after 48-72 hours however increased blood sugar levels and numbness in toes have continued.
fWithin the first 24 hours I had a low grade fever, headache, and chills. About 35 days later I noticed serve pain in my leg and a skin rash which was diagnosed as shlinges.